Godavari Biorefineries Limited — PPTs, 26-05-2025: Investor Presentation

1. Financial Highlights:

Godavari Biorefineries reported consolidated revenue of Rs. 579.5 Cr in Q4 FY25, slightly down from Rs. 615.2 Cr last year. EBITDA rose to Rs. 121.7 Cr with margin improvement to 21.0% versus 20.2% previously. Adjusted PAT was Rs. 71.9 Cr, improving margin to 12.4% from 10.6%. For FY25, revenue grew to Rs. 1,870.3 Cr from Rs. 1,686.7 Cr, though EBITDA margin contracted to 6.4% from 8.8%. PAT stood at Rs. 1.1 Cr. Ethanol production increased notably, supporting the core business.

2. Strategic Initiatives & Growth Drivers:

Advancing a 200 KLPD grain/maize distillery project targeted for Q4 FY26 commissioning, with multi-feedstock flexibility and specialty product capacity upgrades. Enhanced ethanol blending via sugarcane juice restoration and record cane crushing volumes demonstrate operational agility and cost efficiency.

3. Business Developments:

The Bio-based Specialty Chemicals segment delivered over 2x EBITDA growth year-on-year, driven by focus on high-value sustainable chemicals such as MPO and 1,3 butylene glycol, strengthening the product portfolio and footprint.

4. Market Position & Competitive Advantage:

Godavari is a leading Indian ethanol producer and pioneer in ethanol-based specialty chemicals, with a diversified product base unmatched domestically. Its scale, integrated operations, and sustainability efforts provide strong competitive advantages.

5. Investor Implications:

Operational efficiency gains, specialty chemicals growth, and capacity expansion offer positive growth potential. Execution risks related to the new distillery and market volatility in ethanol/chemicals remain key points to monitor. Strategic moves support an optimistic outlook for value creation.